NO20030530L - Tartratsalter av tiazolidindionderivater - Google Patents

Tartratsalter av tiazolidindionderivater

Info

Publication number
NO20030530L
NO20030530L NO20030530A NO20030530A NO20030530L NO 20030530 L NO20030530 L NO 20030530L NO 20030530 A NO20030530 A NO 20030530A NO 20030530 A NO20030530 A NO 20030530A NO 20030530 L NO20030530 L NO 20030530L
Authority
NO
Norway
Prior art keywords
tartrate salts
thiazolidinedione derivatives
thiazolidinedione
derivatives
tartrate
Prior art date
Application number
NO20030530A
Other languages
English (en)
Other versions
NO20030530D0 (no
NO324596B1 (no
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20030530D0 publication Critical patent/NO20030530D0/no
Publication of NO20030530L publication Critical patent/NO20030530L/no
Publication of NO324596B1 publication Critical patent/NO324596B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)
NO20030530A 2000-08-04 2003-02-03 Tartratsalter av tiazolidindionderivat, fremgangsmate for fremstilling derav, farmasoytisk preparat samt anvendelse av tartratsaltet NO324596B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003511 WO2002012232A1 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative

Publications (3)

Publication Number Publication Date
NO20030530D0 NO20030530D0 (no) 2003-02-03
NO20030530L true NO20030530L (no) 2003-02-03
NO324596B1 NO324596B1 (no) 2007-11-26

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030530A NO324596B1 (no) 2000-08-04 2003-02-03 Tartratsalter av tiazolidindionderivat, fremgangsmate for fremstilling derav, farmasoytisk preparat samt anvendelse av tartratsaltet

Country Status (37)

Country Link
US (1) US20040014790A1 (no)
EP (1) EP1305311B1 (no)
JP (1) JP2004505970A (no)
KR (1) KR100755174B1 (no)
CN (1) CN1455778A (no)
AP (1) AP1785A (no)
AT (1) ATE384059T1 (no)
AU (1) AU2001276506A1 (no)
BG (1) BG107604A (no)
BR (1) BR0112982A (no)
CA (1) CA2417827A1 (no)
CY (1) CY1107252T1 (no)
CZ (1) CZ2003313A3 (no)
DE (1) DE60132461T2 (no)
DK (1) DK1305311T3 (no)
DZ (1) DZ3418A1 (no)
EA (1) EA005408B1 (no)
EC (1) ECSP034467A (no)
ES (1) ES2296772T3 (no)
GB (1) GB0019224D0 (no)
HK (1) HK1057358A1 (no)
HR (1) HRP20030068B1 (no)
HU (1) HUP0300778A3 (no)
IL (2) IL154275A0 (no)
MA (1) MA25832A1 (no)
MX (1) MXPA03001085A (no)
NO (1) NO324596B1 (no)
NZ (1) NZ524030A (no)
OA (1) OA12354A (no)
PL (1) PL360662A1 (no)
PT (1) PT1305311E (no)
SI (1) SI1305311T1 (no)
SK (1) SK1462003A3 (no)
UA (1) UA76720C2 (no)
WO (1) WO2002012232A1 (no)
YU (1) YU14603A (no)
ZA (1) ZA200300961B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
CN108348292B (zh) 2015-10-27 2021-04-27 纳诺帕斯技术有限公司 具有机械性导引的微针装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
KR100755174B1 (ko) 2007-09-03
AU2001276506A1 (en) 2002-02-18
JP2004505970A (ja) 2004-02-26
HUP0300778A2 (hu) 2003-11-28
ZA200300961B (en) 2004-04-01
DE60132461T2 (de) 2008-12-24
NZ524030A (en) 2004-07-30
PL360662A1 (en) 2004-09-20
HUP0300778A3 (en) 2005-04-28
SK1462003A3 (en) 2004-06-08
EA005408B1 (ru) 2005-02-24
CY1107252T1 (el) 2012-11-21
WO2002012232A1 (en) 2002-02-14
PT1305311E (pt) 2008-04-07
CN1455778A (zh) 2003-11-12
CA2417827A1 (en) 2002-02-14
AP2003002736A0 (en) 2003-03-31
MA25832A1 (fr) 2003-07-01
YU14603A (sh) 2006-05-25
BR0112982A (pt) 2003-08-26
SI1305311T1 (sl) 2008-04-30
IL154275A (en) 2009-02-11
MXPA03001085A (es) 2003-05-27
EP1305311A1 (en) 2003-05-02
BG107604A (bg) 2003-09-30
US20040014790A1 (en) 2004-01-22
DK1305311T3 (da) 2008-05-19
ATE384059T1 (de) 2008-02-15
DE60132461D1 (de) 2008-03-06
EA200300230A1 (ru) 2003-06-26
AP1785A (en) 2007-10-04
HRP20030068A2 (en) 2005-02-28
KR20030022355A (ko) 2003-03-15
NO20030530D0 (no) 2003-02-03
EP1305311B1 (en) 2008-01-16
UA76720C2 (uk) 2006-09-15
CZ2003313A3 (cs) 2004-02-18
ECSP034467A (es) 2003-03-31
OA12354A (en) 2004-03-19
IL154275A0 (en) 2003-09-17
ES2296772T3 (es) 2008-05-01
NO324596B1 (no) 2007-11-26
DZ3418A1 (fr) 2002-02-14
GB0019224D0 (en) 2000-09-27
HK1057358A1 (en) 2004-04-02
HRP20030068B1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
NO20030134L (no) Fremstilling av olefinderivater
DK1448198T3 (da) Nicotin- eller isonicotin-benzothiazolderivater
ATE391505T1 (de) Benzothiazole derivative
NO20030507D0 (no) Tartratsalter av tiazolidindionderivater
NO20030508L (no) Tartratsalter av tiazolidindionderivater
NO20030530D0 (no) Tartratsalter av tiazolidindionderivater
NO20030531D0 (no) Tartratsalter av tiazolidindionderivater
EE200100381A (et) Morfolinobensamiidi uued soolad
SI1305310T1 (sl) Tartratne soli derivata tiazolidindiona
NO20025385D0 (no) FremgangsmÕte for fremstilling av sulfonylbenzoylguanidiniumsalter

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees